Quantum BioPharma (STU:0K91) Total Assets: €12.91 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STU:0K91 Quantum BioPharma Ltd STU:0K91
38 GF Score
Price €2.64
! 5 Warning Signs
View Full Analysis

What is Quantum BioPharma Total Assets?

Quantum BioPharma STU:0K91 -6.84% 38 Total Assets is €12.91 Mil as of Mar. 2026. GuruFocus rates STU:0K91 with a GF Score™ of 38/100. The stock has 5 warning signs investors should review.

Quantum BioPharma's Total Assets for the quarter that ended in Mar. 2026 was €12.91 Mil.

During the past 12 months, Quantum BioPharma's average Total Assets Growth Rate was -12.60% per year. During the past 3 years, the average Total Assets Growth Rate was -25.30% per year. During the past 5 years, the average Total Assets Growth Rate was -20.30% per year.

During the past 11 years, Quantum BioPharma's highest 3-Year average Total Assets Growth Rate was 2083.10%. The lowest was -26.30%. And the median was -15.85%.

Total Assets is connected with ROA %. Quantum BioPharma's annualized ROA % for the quarter that ended in Mar. 2026 was -418.11%. Total Assets is also linked to Revenue through Asset Turnover. Quantum BioPharma's Asset Turnover for the quarter that ended in Mar. 2026 was 0.00.

Quantum BioPharma  (STU:0K91) Total Assets Explanation

Total Assets is connected with ROA %.

Quantum BioPharma's annualized ROA % for the quarter that ended in Mar. 2026 is

ROA %=Net Income (Q: Mar. 2026 )/( (Total Assets (Q: Dec. 2025 )+Total Assets (Q: Mar. 2026 ))/ count )
=-46.916/( (9.531+12.911)/ 2 )
=-46.916/11.221
=-418.11 %

Note: The Net Income data used here is four times the quarterly (Mar. 2026) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Quantum BioPharma's Asset Turnover for the quarter that ended in Mar. 2026 is

Asset Turnover
=Revenue (Q: Mar. 2026 )/( (Total Assets (Q: Dec. 2025 )+Total Assets (Q: Mar. 2026 ))/ count )
=0/( (9.531+12.911)/ 2 )
=0/11.221
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Quantum BioPharma Total Assets Related Terms

Quantum BioPharma Total Assets Historical Data

* Premium members only.

The historical data trend for Quantum BioPharma's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Quantum BioPharma Total Assets Chart

Quantum BioPharma Annual Data
Trend Aug16 Aug17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 55.72 36.26 16.03 16.35 9.53

Quantum BioPharma Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 13.76 13.26 12.06 9.53 12.91
STU:0K91
38GF Score
Quantum BioPharma Ltd STU:0K91
Total Assets is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Quantum BioPharma Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Quantum BioPharma's Total Assets for the fiscal year that ended in Dec. 2025 is calculated as

Total Assets=Total Equity (A: Dec. 2025 )+Total Liabilities (A: Dec. 2025 )
=4.358+5.174
=9.53

Quantum BioPharma's Total Assets for the quarter that ended in Mar. 2026 is calculated as

Total Assets=Total Equity (Q: Mar. 2026 )+Total Liabilities (Q: Mar. 2026 )
=-1.228+14.139
=12.91

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Assets →
What does a Total Assets of €12.91 Mil mean?
Quantum BioPharma (STU:0K91) has a Total Assets of €12.91 Mil as of Mar. 2026. The total amount of assets as recorded on a company's balance sheet. View historical data on Quantum BioPharma and its competitors.
Is Quantum BioPharma's Total Assets too high?
Quantum BioPharma's current Total Assets is €12.91 Mil. Overall, Quantum BioPharma has a GF Score™ of 38/100, reflecting its overall financial health beyond just this single metric.
How does Quantum BioPharma's Total Assets compare to VRTX and REGN?
Quantum BioPharma's Total Assets of €12.91 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Assets for a Biotechnology company?
A good Total Assets depends on the Biotechnology industry context. However, Total Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Assets mean?
A high Total Assets can signal that a stock is expensive relative to its fundamentals. The total amount of assets as recorded on a company's balance sheet. View historical data on Quantum BioPharma and its competitors. Quantum BioPharma's current Total Assets is €12.91 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Quantum BioPharma stock overvalued right now?
Quantum BioPharma (STU:0K91) has a current Total Assets of €12.91 Mil. The current Total Assets is €12.91 Mil. Quantum BioPharma's overall GF Score™ is 38/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Assets calculated?
Total Assets is calculated from a company's financial statements. For Quantum BioPharma (STU:0K91), the current Total Assets is €12.91 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Quantum BioPharma Business Description

Other Exchanges QNTM:USAQNTM:Canada
Address 1 Adelaide Street East, Suite 801, Toronto, ON, CAN, M5C 2V9
Quantum BioPharma Ltd is a biopharmaceutical company dedicated to building a portfolio of inventive assets and biotech solutions for the treatment of challenging neurodegenerative and metabolic disorders and alcohol misuse disorders with drug candidates in different stages of development. Through its wholly owned subsidiary, it is focused on the research and development of its lead compound, Lucid-MS. Lucid-MS is a patented new chemical entity shown to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis, in preclinical models. The company maintains a portfolio of strategic investments through its wholly owned subsidiary, which represents loans secured by residential or commercial property.
38GF Score

Get the complete analysis for STU:0K91

Total Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€2.64
Price